Reports

      Are heated tobacco products (HTPs) a public health opportunity?

      Costanzo, R.; Baker, G.

      Published on
      Feb 17, 2021
      Link to publication
      Topic
      Summary

      Heated tobacco products (HTPs) are a new, rapidly emerging category of tobacco products that are designed to heat the tobacco instead of burning it, thus substantially reducing the emission of harmful chemicals. Currently there is a debate about whether HTPs provide an opportunity for public health, to accelerate the decline in cigarette smoking prevalence and thereby smoking-related population harm. To answer this question, HTPs have to be scientifically substantiated to reduce the harm to the individual smoker, but they also have to be satisfying for adult smokers to maximize the number of adult smokers who switch, while minimizing the number of youths and non-smokers who initiate or relapse to these products, as well as minimizing the number of smokers who intend to quit who may use those products instead. In this article we present the evidence showing that switching to the THS reduces the negative health effects that are triggered by chronic exposure to the toxic substances generated during tobacco combustion and that lead to disease, compared to continuing smoking.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.